为解决 HRD 状态检测困难及 PARPi 治疗患者精准筛选问题，研究人员开展 HRD 检测相关研究。结果表明现有多种检测方法各有利弊。这为临床选择合适检测手段、精准治疗癌症提供依据，强烈推荐科研读者阅读。

The Amsterdam-based company recently received IVDR certification for other tests including one for phenylketonuria.

在医学领域，癌症一直被视为一种复杂而难以捉摸的疾病。其发病机理涉及遗传、环境、生活方式等多种因素，使得癌症的预防和治疗充满了挑战。长久以来，关于癌症是否由基因注定，是否真的会“遗传”给下一代的讨论不绝于耳。本文将深入探讨癌症的遗传性问题，特别是当父母 ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

MRC Holland recently announced that five SALSA MLPA assays for the detection of hereditary breast and ovarian cancer (HBOC) ...

为解决传统 BRCA1 检测方法的局限，伊朗研究人员开展纳米材料基生物传感器用于乳腺癌诊断的研究。结果显示这类传感器有高灵敏度等优势。推荐科研读者阅读，助力探索乳腺癌诊断新方向。 在全球范围内，乳腺癌就像一个 “健康杀手”，严重威胁着人们的生命健康。2020 年，全球大约有 230 万新的乳腺癌病例，68.5 万人因乳腺癌离世。而且，不同国家的乳腺癌发病率和死亡率差异很大，比如比利时每 10 ...

For years, breast cancer treatment has been guided by genetic alterations found in tumor tissue, typically through invasive biopsies.

A new study on circulating tumor DNA (ctDNA) testing for advanced breast cancer has unveiled encouraging results, with high ...

BOISE — A bill that would require private Idaho health insurers to cover supplemental breast cancer screenings for high-risk ...

A bill that would require private Idaho health insurers to cover supplemental breast cancer screenings for high-risk patients has advanced to the House floor.

Stanford scientists have identified 380 key genetic variants that significantly influence cancer development, filtering ...

A bill that would require private Idaho health insurers to cover supplemental breast cancer screenings for high-risk patients ...